Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Cancer stem cells (CSCs) are a rare population with self-renewal and multipotent differentiation capacity, and reside among the more differentiated cancer cells. CSCs are associated with tumor recurrence, drug resistance...
Main Authors: | Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.597520/full |
Similar Items
-
Napabucasin Induces Mouse Bone Loss by Impairing Bone Formation via STAT3
by: Xiangru Huang, et al.
Published: (2021-03-01) -
The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
by: Marlena Beyreis, et al.
Published: (2019-02-01) -
Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells
by: Dongfeng Han, et al.
Published: (2019-07-01) -
Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers
by: Naoto Noda, et al.
Published: (2021-10-01) -
The role of SOCS proteins in the development of virus- induced hepatocellular carcinoma
by: Jinyan Xie, et al.
Published: (2021-04-01)